Larotrectinib

Status:

Red

Decision Date:

December 2019

Comments

NICE TA630: For treating neurotrophic tyrosine receptor kinase (NTRK) fusion positive solid tumours (Decision date - June 2020)

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again